{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:34:19Z","timestamp":1777581259380,"version":"3.51.4"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Osteopontin (OPN) or secreted phosphoprotein 1 (SPP1) is a matricellular glycoprotein whose expression is elevated in various types of cancer and has been shown to be involved in tumourigenesis and metastasis in many malignancies, including follicular cell-derived thyroid carcinomas. Its role in C-cell-derived thyroid lesions and tumours remains to be established.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The objective of this study is to clarify the role of OPN expression in the development of medullary thyroid carcinoma (MTC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>OPN expression was analysed in a series of 116 MTCs by immunohistochemistry and by qPCR mRNA quantification of the 3 OPN isoforms (OPNa, OPNb and OPNc) in six cases from which fresh frozen tissue was available. Statistical tests were used to evaluate the relationship of OPN expression and the clinicopathological and molecular characteristics of patients and tumours.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>OPN expression was detected in 91 of 116 (78.4%) of the MTC. We also observed high OPN expression in C-cell hyperplasia as well as in C-cells scattered in the thyroid parenchyma adjacent to the tumours. OPN expression was significantly associated with smaller tumour size, <jats:italic>PTEN<\/jats:italic> nuclear expression and <jats:italic>RAS<\/jats:italic> status, and suggestively associated with non-invasive tumours. OPNa isoform was expressed significantly at higher levels in tumours than in non-tumour samples. OPNb and OPNc presented similar levels of expression in all samples. Furthermore, OPNa isoform overexpression was significantly associated with reduced growth and viability in the MTC-derived cell line (TT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The expression of OPN in normal C-cells and C-cell hyperplasia suggests that OPN is a differentiation marker of C-cells, rather than a marker of biological aggressiveness in this setting. At variance with other cancers, OPN expression is associated with good prognostic features in MTC.<\/jats:p><\/jats:sec>","DOI":"10.1530\/eje-15-0577","type":"journal-article","created":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T03:48:50Z","timestamp":1453780130000},"page":"551-561","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":19,"title":["Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma"],"prefix":"10.1093","volume":"174","author":[{"given":"Luciana Bueno","family":"Ferreira","sequence":"first","affiliation":[]},{"given":"Catarina","family":"Eloy","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Pestana","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Lyra","sequence":"additional","affiliation":[]},{"given":"Margarida","family":"Moura","sequence":"additional","affiliation":[]},{"given":"Hugo","family":"Prazeres","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Tavares","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Sobrinho-Sim\u00f5es","sequence":"additional","affiliation":[]},{"given":"Etel","family":"Gimba","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Soares","sequence":"additional","affiliation":[]}],"member":"286","reference":[{"key":"2016022218335303000_174.4.551.1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clon.2010.05.002","article-title":"Medullary thyroid carcinoma","volume":"22","author":"Pacini","year":"2010","journal-title":"Clinical Oncology"},{"key":"2016022218335303000_174.4.551.2","doi-asserted-by":"publisher","DOI":"10.1067\/mhn.2003.2"},{"key":"2016022218335303000_174.4.551.3","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.12.10370"},{"key":"2016022218335303000_174.4.551.4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0065-1281(11)80064-4","article-title":"Evaluation of the role of mammalian thyroid parafollicular cells","volume":"97","author":"Sawicki","year":"1995","journal-title":"Acta Histochemica"},{"key":"2016022218335303000_174.4.551.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012915"},{"key":"2016022218335303000_174.4.551.6","first-page":"184","article-title":"The expression of twist in differentiated thyroid carcinomas","volume":"40","author":"Calangiu","year":"2014","journal-title":"Current Health Sciences Journal"},{"key":"2016022218335303000_174.4.551.7","doi-asserted-by":"crossref","first-page":"e100534","DOI":"10.1371\/journal.pone.0100534","article-title":"Survivin delta Ex3 overexpression in thyroid malignancies","volume":"9","author":"Waligorska-Stachura","year":"2014","journal-title":"PLoS ONE"},{"key":"2016022218335303000_174.4.551.8","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-014-0204-3"},{"key":"2016022218335303000_174.4.551.9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207322"},{"key":"2016022218335303000_174.4.551.10","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.3.10.1169"},{"key":"2016022218335303000_174.4.551.11","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22523"},{"key":"2016022218335303000_174.4.551.12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ajpath.2013.11.020","article-title":"Osteopontin promotes the invasive growth of melanoma cells by activating integrin alphavbeta3 and down-regulating tetraspanin CD9","volume":"184","author":"Yin","year":"2014","journal-title":"American Journal of Pathology"},{"key":"2016022218335303000_174.4.551.13","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-10-0463"},{"key":"2016022218335303000_174.4.551.14","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgt218"},{"key":"2016022218335303000_174.4.551.15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4174\/jkss.2013.84.1.9","article-title":"Osteopontin expression in papillary thyroid carcinoma and its relationship with the BRAF mutation and tumor characteristics","volume":"84","author":"Kang","year":"2013","journal-title":"Journal of the Korean Surgical Society"},{"key":"2016022218335303000_174.4.551.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.10.015"},{"key":"2016022218335303000_174.4.551.17","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2816"},{"key":"2016022218335303000_174.4.551.18","first-page":"1455","article-title":"Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factor","volume":"41","author":"Liersch","year":"2012","journal-title":"International journal of oncology"},{"key":"2016022218335303000_174.4.551.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-011-1024-y"},{"key":"2016022218335303000_174.4.551.20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-237"},{"key":"2016022218335303000_174.4.551.21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00795-007-0348-9","article-title":"Large cell neuroendocrine carcinoma of the lung with calcification and expression of osteopontin","volume":"40","author":"Kuroda","year":"2007","journal-title":"Medical Molecular Morphology"},{"key":"2016022218335303000_174.4.551.22","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4644(20000601)77:3<487::AID-JCB13>3.0.CO;2-8"},{"key":"2016022218335303000_174.4.551.23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209248"},{"key":"2016022218335303000_174.4.551.24","first-page":"1409","article-title":"Osteopontin splice variants differentially modulate the migratory activity of hepatocellular carcinoma cell lines","volume":"35","author":"Chae","year":"2009","journal-title":"International journal of oncology"},{"key":"2016022218335303000_174.4.551.25","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0389"},{"key":"2016022218335303000_174.4.551.26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1921"},{"key":"2016022218335303000_174.4.551.27","first-page":"283","article-title":"Characterisation of thyroid medullary carcinoma TT cell line","volume":"12","author":"Zabel","year":"1997","journal-title":"Histology and Histopathology"},{"key":"2016022218335303000_174.4.551.28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jmau.2013.07.001","article-title":"Osteopontin cytoplasmic immunoexpression is a predictor of poor disease-free survival in thyroid cancer","volume":"1","author":"Gomaa","year":"2013","journal-title":"Journal of Microscopy and Ultrastructure"},{"key":"2016022218335303000_174.4.551.29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.7863\/jum.2011.30.6.765","article-title":"Correlation between osteopontin messenger RNA expression and microcalcification shown on sonography in papillary thyroid carcinoma","volume":"30","author":"Sun","year":"2011","journal-title":"Journal of Ultrasound in Medicine"},{"key":"2016022218335303000_174.4.551.30","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-1405-2"},{"key":"2016022218335303000_174.4.551.31","first-page":"1681","article-title":"Osteopontin (OPN) expression in thyroid carcinoma","volume":"30","author":"Briese","year":"2010","journal-title":"Anticancer Research"},{"key":"2016022218335303000_174.4.551.32","first-page":"1087","article-title":"Possible relation of osteopontin to development of psammoma bodies in human papillary thyroid cancer","volume":"122","author":"Tunio","year":"1998","journal-title":"Archives of Pathology"},{"key":"2016022218335303000_174.4.551.33","first-page":"610","article-title":"Osteopontin expression and distribution in human carcinomas","volume":"145","author":"Brown","year":"1994","journal-title":"American Journal of Pathology"},{"key":"2016022218335303000_174.4.551.34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0271"},{"key":"2016022218335303000_174.4.551.35","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jbmr.5650070704","article-title":"Bone matrix mRNA expression in differentiating fetal bovine osteoblasts","volume":"7","author":"Ibaraki","year":"1992","journal-title":"Journal of Bone and Mineral Research"},{"key":"2016022218335303000_174.4.551.36","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.0.CO;2-B"},{"key":"2016022218335303000_174.4.551.37","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1997.0151"},{"key":"2016022218335303000_174.4.551.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2006.12.026"},{"key":"2016022218335303000_174.4.551.39","doi-asserted-by":"publisher","DOI":"10.1369\/jhc.7A7325.2007"},{"key":"2016022218335303000_174.4.551.40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.matbio.2014.03.001","article-title":"Role of osteopontin in the pathophysiology of cancer","volume":"37","author":"Shevde","year":"2014","journal-title":"Matrix Biology"},{"key":"2016022218335303000_174.4.551.41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0802301105"},{"key":"2016022218335303000_174.4.551.42","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-010-8179-5"},{"key":"2016022218335303000_174.4.551.43","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2002.17.8.1486"},{"key":"2016022218335303000_174.4.551.44","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10394"},{"key":"2016022218335303000_174.4.551.45","doi-asserted-by":"publisher","DOI":"10.1038\/nri2460"},{"key":"2016022218335303000_174.4.551.46","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl177"},{"key":"2016022218335303000_174.4.551.47","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210175"},{"key":"2016022218335303000_174.4.551.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.11.042"},{"key":"2016022218335303000_174.4.551.49","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209299200"},{"key":"2016022218335303000_174.4.551.50","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970904)72:5<739::AID-IJC6>3.0.CO;2-T"},{"key":"2016022218335303000_174.4.551.51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1022550721404","article-title":"Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter","volume":"20","author":"Denhardt","year":"2003","journal-title":"Clinical & Experimental Metastasis"},{"key":"2016022218335303000_174.4.551.52","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1128\/MCB.15.1.476","article-title":"Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell","volume":"15","author":"Guo","year":"1995","journal-title":"Molecular and Cell Biology"},{"key":"2016022218335303000_174.4.551.53","first-page":"159","article-title":"High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis","volume":"4","author":"Lemoine","year":"1989","journal-title":"Oncogene"},{"key":"2016022218335303000_174.4.551.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2012.12.003"},{"key":"2016022218335303000_174.4.551.55","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jtcvs.2009.08.016","article-title":"Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity","volume":"139","author":"Blasberg","year":"2010","journal-title":"Journal of Thoracic and Cardiovascular Surgery"},{"key":"2016022218335303000_174.4.551.56","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1097\/JTO.0b013e3181eba6bd","article-title":"Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer","volume":"5","author":"Goparaju","year":"2010","journal-title":"Journal of Thoracic Oncology"},{"key":"2016022218335303000_174.4.551.57","doi-asserted-by":"publisher","DOI":"10.1002\/mc.20105"},{"key":"2016022218335303000_174.4.551.58","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1245\/s10434-012-2337-z","article-title":"Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinoma","volume":"19","author":"Collins","year":"2012","journal-title":"Annual Surgery and Oncology"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/174\/4\/551.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/174\/4\/551.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T16:33:02Z","timestamp":1676392382000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/174\/4\/551\/6655097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":58,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1530\/eje-15-0577","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}